{"id":"W2128628205","doi":"10.1016/s1470-2045(13)70479-0","title":"Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Bristol-Myers Squibb (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Dasatinib; Docetaxel; Prostate cancer; Internal medicine; Oncology; Clinical endpoint; Placebo; Chemotherapy; Cancer; Urology; Clinical trial; Tyrosine kinase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001997387,0.002598237,0.005155811,0.0005656238,0.0006697873,0.001456985,0.001209161,0.002327584,0.01116917],"category_scores_gemma":[0.002344853,0.001226094,0.003272964,0.0005813091,0.001996329,0.001878466,0.0006334881,0.004348835,0.001831853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008497442,"about_ca_system_score_gemma":0.001118968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001546452,"about_ca_topic_score_gemma":0.003894736,"domain_scores_codex":[0.9990671,0.0004844859,0.00006295306,0.0001897231,0.00004970721,0.0001460022],"domain_scores_gemma":[0.9990526,0.0003215491,0.000185274,0.00008392198,0.00005274355,0.0003038095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9889548,0.001411335,0.0001247359,0.0007115704,0.0008301171,0.00002190754,0.00004283944,0.0002188629,0.0006853657,0.00008919374,0.000551714,0.006357761],"study_design_scores_gemma":[0.9815744,0.0173521,0.0002627472,0.00002010307,0.0002248342,0.00001435383,0.00001693369,0.00009272951,0.00007268496,0.00009506207,0.0002631751,0.00001101742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9626991,0.01760709,0.001410103,0.001785104,0.002403453,0.007362301,0.002281949,0.000379564,0.004071461],"genre_scores_gemma":[0.9773746,0.00693663,0.001539904,0.001488604,0.0007075183,0.004495009,0.001138714,0.00005583285,0.006263257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01116917,"threshold_uncertainty_score":0.0373646,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1322022653686313,"score_gpt":0.4325167925736302,"score_spread":0.3003145272049989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}